최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of biological macromolecules, v.202, 2022년, pp.11 - 25
Khushbu (Corresponding author.) , Jindal, Rajeev
Abstract The objective of the study is to enhance the aqueous solubility and stability of edaravone, a free radical scavenger drug. Inclusion complexes of edaravone with β-cyclodextrin were prepared by microwave irradiation and physical mixture method and confirmation of inclusion complexes we...
RSC Adv. Jafarbeglou 6 50002 2016 10.1039/C6RA03942A Clay nanocomposites as engineered drug delivery systems
Clay Miner. Hosseini 53 53 2018 10.1180/clm.2018.4 Bentonite nanoclay-based drug-delivery systems for treating melanoma
Bull. Mater. Sci. Patel 29 133 2006 10.1007/BF02704606 Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment
J. Solid State Chem. Wei 177 2534 2004 10.1016/j.jssc.2004.03.041 Studies on the intercalation of naproxen into layered double hydroxide and its thermal decomposition by in situ FT-IR and in situ HT-XRD
Int. J. Biol. Macromol. Zia 49 1131 2011 10.1016/j.ijbiomac.2011.09.010 Cytotoxicity and mechanical behavior of chitin-bentonite clay based polyurethane bio-nanocomposites
J. Appl. Polym. Sci. Lee 91 2934 2004 10.1002/app.13499 Effect of bentonite on the physical properties and drug-release behavior of poly(AA-co-PEGMEA)/bentonite nanocomposite hydrogels for mucoadhesive
ACS Omega Zhang 2020 Structure regulation of bentonite-alginate nanocomposites for controlled release of imidacloprid
Appl. Clay Sci. Singh 47 384 2010 10.1016/j.clay.2009.12.001 Controlled release of thiram from neem-alginate-clay based delivery systems to manage environmental and health hazards
Int. J. Biol. Macromol. Kumar 81 631 2015 10.1016/j.ijbiomac.2015.08.062 Development and evaluation of alginate-chitosan nanocapsules for controlled release of acetamiprid
Int. J. Biol. Macromol. Liang 112 258 2018 10.1016/j.ijbiomac.2018.01.174 Chitosan-based nanoparticles of avermectin to control pine wood nematodes
J. Drug Deliv. Sci. Technol. Khushbu 61 2021 RSM-CCD optimized microwave assisted synthesis of chitosan and sodium alginate based nanocomposite containing inclusion complexes of β-cyclodextrin and amlodipine besylate for sustained drug delivery systems
ACS Appl. Mater. Interfaces Sheng 7 15430 2015 10.1021/acsami.5b03555 N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption
Jindal 2021 Comparative Evaluation for Controlled Release of Amoxicillin From RSM-CCD-optimized Nanocomposites Based on Sodium Alginate and Chitosan-containing Inclusion Complexes
Molecules Li 23 1 2018 Chitosan-based nanomaterials for drug delivery
ACS Appl. Mater. Interfaces Hardy 10 29347 2018 10.1021/acsami.8b09733 β-Cyclodextrin-functionalized chitosan/alginate compact polyelectrolyte complexes (CoPECs) as functional biomaterials with anti-inflammatory properties
Pharmaceutics Mohammed 9 2017 10.3390/pharmaceutics9040053 An overview of chitosan nanoparticles and its application in non-parenteral drug delivery
Front. Bioeng.Biotechnol. Saeed 8 1 2020 10.3389/fbioe.2020.00004 Stable chitosan-based nanoparticles using polyphosphoric acid or hexametaphosphate for tandem ionotropic/covalent crosslinking and subsequent investigation as novel vehicles for drug delivery
Int. J. Biol. Macromol. Hejjaji 120 1610 2018 10.1016/j.ijbiomac.2018.09.185 Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using different chitosan to tripolyphosphate (CS:TPP) ratios
J.Drug Deliv. Sci.Technol. Kaur 48 161 2018 10.1016/j.jddst.2018.09.003 RSM-CCD optimized microwave-assisted synthesis of chitosan and gelatin-based pH sensitive, inclusion complexes incorporated hydrogels and their use as controlled drug delivery systems
J. Mater. Chem. B Flynn 8 4029 2020 10.1039/D0TB00169D Tuning the strength and swelling of an injectable polysaccharide hydrogel and the subsequent release of a broad spectrum bacteriocin, nisin A
Curr. Drug Deliv. Giri 9 539 2012 10.2174/156720112803529800 Alginate based hydrogel as a potential biopolymeric carrier for drug delivery and cell delivery systems: present status and applications
J. Biol. Engineering. Abasalizadeh 14 1 2020 Erratum: Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting (Journal of Biological Engineering (2020) 14: 8 DOI: 10.1186/s13036-020-0227-7)
Biofabrication Decante 13 2021 10.1088/1758-5090/abec2c Engineering bioinks for 3D bioprinting
Adv. Pharmacol.Pharm. Sci. Hariyadi 2020 2020 Current status of alginate in drug delivery
Mater. Sci. Eng. C Serafin 122 2021 10.1016/j.msec.2021.111927 Printable alginate/gelatin hydrogel reinforced with carbon nanofibers as electrically conductive scaffolds for tissue engineering
Transplant. Proc. Nakamura 40 2171 2008 10.1016/j.transproceed.2008.06.049 A free radical scavenger, edaravone, prevents ischemia-reperfusion injury in liver grafts from non-heart-beating donors
Int. J. Pharm. Sato 372 33 2009 10.1016/j.ijpharm.2008.12.038 A novel administration route for edaravone: I. Effects of metabolic inhibitors on skin permeability of edaravone
J. Cardiol. Nakamura 54 416 2009 10.1016/j.jjcc.2009.07.001 The effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction
Heart Vessel. Yamazaki 24 228 2009 10.1007/s00380-008-1106-1 Effect of edaravone, a novel free radical scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart
Carbohydr. Polym. Zeng 83 1101 2011 10.1016/j.carbpol.2010.09.007 Preparation and physicochemical characteristics of the complex of edaravone with hydroxypropyl-β-cyclodextrin
Process Biochem. Del Valle 39 1033 2004 10.1016/S0032-9592(03)00258-9 Cyclodextrins and their uses: a review
Polym. Bull. Kaur 76 3569 2019 10.1007/s00289-018-2555-z Exploring RSM-CCD-optimized chitosan-/gelatin-based hybrid polymer network containing CPM-β-CD inclusion complexes as controlled drug delivery systems
Sci. Rep. Saha 6 1 2016 10.1038/srep35764 Study to explore the mechanism to form inclusion complexes of β-cyclodextrin with vitamin molecules
Beilstein J. Org. Chem. Fifere 8 2191 2012 10.3762/bjoc.8.247 Theoretical study on β-cyclodextrin inclusion complexes with propiconazole and protonated propiconazole
journal of developingDrugs Baishya 06 1 2017 Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets
Chem. Rev. Connors 97 1325 1997 10.1021/cr960371r The stability of cyclodextrin complexes in solution
A Simple Equation for Description of Solute Release Ritger 5 37 1987
Int. J. Pharm. Loftsson 302 18 2005 10.1016/j.ijpharm.2005.05.042 Evaluation of cyclodextrin solubilization of drugs
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.